These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31851699)

  • 1. Identification of Plasmodium dipeptidyl aminopeptidase allosteric inhibitors by high throughput screening.
    Sanchez MI; de Vries LE; Lehmann C; Lee JT; Ang KK; Wilson C; Chen S; Arkin MR; Bogyo M; Deu E
    PLoS One; 2019; 14(12):e0226270. PubMed ID: 31851699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium falciparum dipeptidyl aminopeptidase 3 activity is important for efficient erythrocyte invasion by the malaria parasite.
    Lehmann C; Tan MSY; de Vries LE; Russo I; Sanchez MI; Goldberg DE; Deu E
    PLoS Pathog; 2018 May; 14(5):e1007031. PubMed ID: 29768491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of P. falciparum dipeptidyl aminopeptidase 3 specificity identifies differences in amino acid preferences between peptide-based substrates and covalent inhibitors.
    de Vries LE; Sanchez MI; Groborz K; Kuppens L; Poreba M; Lehmann C; Nevins N; Withers-Martinez C; Hirst DJ; Yuan F; Arastu-Kapur S; Horn M; Mares M; Bogyo M; Drag M; Deu E
    FEBS J; 2019 Oct; 286(20):3998-4023. PubMed ID: 31177613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel broad-spectrum activity-based probes to profile malarial cysteine proteases.
    Tan MSY; Davison D; Sanchez MI; Anderson BM; Howell S; Snijders A; Edgington-Mitchell LE; Deu E
    PLoS One; 2020; 15(1):e0227341. PubMed ID: 31923258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library.
    González-Bacerio J; Maluf SEC; Méndez Y; Pascual I; Florent I; Melo PMS; Budu A; Ferreira JC; Moreno E; Carmona AK; Rivera DG; Alonso Del Rivero M; Gazarini ML
    Bioorg Med Chem; 2017 Sep; 25(17):4628-4636. PubMed ID: 28728898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Plasmodium falciparum cysteine proteases by the sugarcane cystatin CaneCPI-4.
    Melo PMS; El Chamy Maluf S; Azevedo MF; Paschoalin T; Budu A; Bagnaresi P; Henrique-Silva F; Soares-Costa A; Gazarini ML; Carmona AK
    Parasitol Int; 2018 Apr; 67(2):233-236. PubMed ID: 29288140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium dipeptidyl aminopeptidases as malaria transmission-blocking drug targets.
    Tanaka TQ; Deu E; Molina-Cruz A; Ashburne MJ; Ali O; Suri A; Kortagere S; Bogyo M; Williamson KC
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4645-52. PubMed ID: 23836185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Falcipains and other cysteine proteases of malaria parasites.
    Rosenthal PJ
    Adv Exp Med Biol; 2011; 712():30-48. PubMed ID: 21660657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional studies of Plasmodium falciparum dipeptidyl aminopeptidase I using small molecule inhibitors and active site probes.
    Deu E; Leyva MJ; Albrow VE; Rice MJ; Ellman JA; Bogyo M
    Chem Biol; 2010 Aug; 17(8):808-19. PubMed ID: 20797610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium falciparum metacaspase PfMCA-1 triggers a z-VAD-fmk inhibitable protease to promote cell death.
    Meslin B; Beavogui AH; Fasel N; Picot S
    PLoS One; 2011; 6(8):e23867. PubMed ID: 21858231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium falciparum M1-aminopeptidase: a promising target for the development of antimalarials.
    González-Bacerio J; Fando R; del Monte-Martínez A; Charli JL; Chávez Mde L
    Curr Drug Targets; 2014; 15(12):1144-65. PubMed ID: 25341419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary flavonoids fisetin and myricetin: dual inhibitors of Plasmodium falciparum falcipain-2 and plasmepsin II.
    Jin H; Xu Z; Cui K; Zhang T; Lu W; Huang J
    Fitoterapia; 2014 Apr; 94():55-61. PubMed ID: 24468190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets.
    Qidwai T
    Curr Drug Targets; 2015; 16(10):1133-41. PubMed ID: 25738296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit
    Sosa Y; Deniskin R; Frame IJ; Steiginga MS; Bandyopadhyay D; Graybill TL; Kallal LA; Ouellette MT; Pope AJ; Widdowson KL; Young RJ; Akabas MH
    ACS Infect Dis; 2019 Oct; 5(10):1738-1753. PubMed ID: 31373203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum.
    Singh A; Rosenthal PJ
    Antimicrob Agents Chemother; 2001 Mar; 45(3):949-51. PubMed ID: 11181388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteine proteases of malaria parasites.
    Rosenthal PJ
    Int J Parasitol; 2004 Dec; 34(13-14):1489-99. PubMed ID: 15582526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.
    Moura PA; Dame JB; Fidock DA
    Antimicrob Agents Chemother; 2009 Dec; 53(12):4968-78. PubMed ID: 19752273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 3,4-Dihydro-2
    Hartuti ED; Sakura T; Tagod MSO; Yoshida E; Wang X; Mochizuki K; Acharjee R; Matsuo Y; Tokumasu F; Mori M; Waluyo D; Shiomi K; Nozaki T; Hamano S; Shiba T; Kita K; Inaoka DK
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281290
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical characterization of Plasmodium falciparum dipeptidyl aminopeptidase 1.
    Wang F; Krai P; Deu E; Bibb B; Lauritzen C; Pedersen J; Bogyo M; Klemba M
    Mol Biochem Parasitol; 2011 Jan; 175(1):10-20. PubMed ID: 20833209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage-specific antimalarial activity of cysteine protease inhibitors.
    Shenai BR; Semenov AV; Rosenthal PJ
    Biol Chem; 2002 May; 383(5):843-7. PubMed ID: 12108550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.